Comments
Loading...
bluebird bio Stock Guidance | NASDAQ:BLUE | Benzinga
bluebird bio issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/2024 | BLUE | bluebird bio | Q4 | 2024 | — | — | — | $25.00M | — | $29.40M | Get Alert |
FAQ
What is the most recent guidance for bluebird bio (BLUE)?
There have been no specific sales or earnings guidance reported for bluebird bio in recent months.
Browse guidance and forecast on all stocks.